About Eska Pharma
Eska Pharma is a private limited company (BVBA/SPRL, legacy) based in Brussel, founded in 2011. Its main activity is classified as "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies". For the 2025 financial year, Eska Pharma reported a profit of €105,760. That makes 6 profitable financial years in a row for Eska Pharma. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €155,405, up 35% on 2024. Equity stands at €690,490, a solvency ratio of 41%. In 2012 it was €72,591. 14 annual accounts are available, covering 2012 to 2025.
- Sectors
- Consultancy firms
- Activities
- Signals
-
Poor liquidityPoor liquidity 0.44
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 106KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 690KStrong equity provides a buffer against setbacks.
Low riskLow risk 40.9%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 121KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 154KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
155K
|
€
115K
|
€
93K
|
€
282K
|
|
|
€
154K
|
€
111K
|
€
88K
|
€
281K
|
|
|
€
106K
|
€
57K
|
€
18K
|
€
213K
|
|
|
€
690K
|
€
585K
|
€
528K
|
€
510K
|
|
|
40.90%
|
36.22%
|
31.82%
|
30.93%
|
|
|
€
998K
|
€
1.03M
|
€
1.13M
|
€
1.14M
|
|
|
€
10K
|
€
716
|
€
17K
|
€
10K
|
Publications 5
All publications- Me. - Comptes Annuels 31.12.2015, App 28.05.2016, Dpt 17.06.2016 16197-0073-011 23/06/2016
- Me. - Comptes Annuels 31.12.2014, App 23.05.2015, Dpt 06.07.2015 15279-0335-010 10/07/2015
- Me. - Comptes Annuels 31.12.2013, App 24.05.2014, Dpt 27.06.2014 14241-0003-010 04/07/2014
- Me. - Comptes Annuels 31.12.2012, App 25.05.2013, Dpt 27.08.2013 13493-0464-010 04/09/2013
- Rubrique Constitution (Nouvelle Personne Morale, Ouverture Succursale, Etc...) 18/10/2011
Frequently asked questions
Answers to the most common questions about Eska Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Eska Pharma?
The VAT number of Eska Pharma is BE0840.007.528.
When was Eska Pharma established?
Eska Pharma was founded in 06-10-2011.
What is the official address of Eska Pharma?
The official address of Eska Pharma is Antoine Dansaertstraat 1 Brussel 1000.
What is the legal form of Eska Pharma?
The juridical form of Eska Pharma is Private limited company (BVBA/SPRL, legacy).
What is the annual revenue of Eska Pharma?
The 2025 accounts of Eska Pharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Eska Pharma a reliable company?
Eska Pharma is a registered Rechtspersoon with company number 0840.007.528 and can be verified through the official CBE database.
What is the credit limit of Eska Pharma?
The estimated credit limit of Eska Pharma is €161,162.
Is Eska Pharma still active?
Eska Pharma currently has the status "Normal situation" and is active.